02186 綠葉製藥
按盘价 
2.800 -0.040 (-1.408%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | 1.982% | 1.713% | 2.142% | 2.583% | -0.622% |
| 股东资金回报率 (%) | 4.212% | 3.653% | 4.772% | 6.584% | -1.702% |
| 资本运用回报率 (%) | 2.703% | 2.504% | 3.069% | 4.097% | -0.881% |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 65.985% | 66.721% | 68.438% | 69.220% | 65.319% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 38.143% | 34.778% | 31.897% | 28.810% | 15.464% |
| 税前边际利润率 (%) | 14.974% | 13.845% | 11.397% | 11.197% | -1.434% |
| 纯利率 (%) | 9.808% | 7.785% | 8.670% | 10.111% | -2.584% |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 1.533 X | 1.236 X | 1.315 X | 1.137 X | 1.418 X |
| 速动比率 (X) | 1.437 X | 1.151 X | 1.214 X | 1.055 X | 1.317 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 44.070% | 46.800% | 46.928% | 54.466% | 59.641% |
| 总债项 / 总资产比率 (%) | 28.689% | 34.854% | 33.047% | 37.545% | 42.028% |
| 净债项 / 总资产比率 (%) | 15.006% | 18.181% | 20.341% | 27.962% | 31.231% |
| 总债项 / 股东资金比率 (%) | 60.035% | 75.374% | 69.362% | 89.471% | 115.802% |
| 长期债项 / 股东资金比率 (%) | 17.360% | 19.981% | 26.581% | 22.256% | 51.583% |
| 净债项 / 股东资金比率 (%) | 31.402% | 39.318% | 42.693% | 66.635% | 86.051% |
| 净现金 / (债项) ($) | (49.26亿) | (53.84亿) | (51.85亿) | (67.81亿) | (70.53亿) |
| 每股净现金 / (债项) ($) | (1.233) | (1.431) | (1.378) | (1.910) | (1.991) |
| 总债项 / 资本运用比率 (%) | 41.142% | 54.774% | 48.545% | 61.674% | 62.227% |
| 利息盈利率 (X) | 2.376 X | 2.494 X | 2.036 X | 2.420 X | 0.813 X |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 158.911日 | 157.398日 | 150.676日 | 150.596日 | 137.485日 |
| 应收贸易帐周转率日数 (日) | 174.696日 | 154.722日 | 123.074日 | 108.273日 | 116.450日 |
| 应付贸易帐周转率日数 (日) | 53.304日 | 43.852日 | 39.427日 | 34.502日 | 37.065日 |
| 备注： | 实时报价更新时间为10/04/2026 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 618,747 |
| 增长率 | 31.122% |
| 每股盈利/(亏损) | RMB 0.159 |
| 每股账面资产净值 (¥) | RMB 3.927 |